Skip to main content

Table 1 Associations of KLK mRNA expression with clinical parameters in advanced high-grade serous ovarian cancer

From: Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer

Clinical parameters KLK7a
low/high
KLK5 + KLK7b
low/high
Age p = 0.564 p = 0.141
≤ 60 years 40/18 26/32
> 60 years 56/25 46/34
Residual tumor mass p = 0.234 p = 0.041
0 mm 51/19 43/27
> 0 mm 44/23 29/37
Ascites fluid volume p = 0.261 p = 0.244
≤ 500 ml 54/24 45/32
> 500 ml 41/13 26/28
  1. a Chi-square test (cut-off point: KLK7 = 67th percentile)
  2. b Chi-square test (dichotomized into low level by KLK5 low and KLK7 low, and high level by KLK5 high and/or KLK7 high; cut-off point: KLK5 = 67th percentile, KLK7 = 67th percentile)
  3. Due to missing values, numbers do not always add up to n = 139.